Dr. Gandhi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
150 Parkway Office Ct
Ste 200
Cary, NC 27518Phone+1 984-974-2150Fax+1 984-974-2151
Summary
- I am board certified in Medical Oncology, Hematology, and Internal Medicine.
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
Icahn School of Medicine at Mount Sinai/Morningside/WestChief Residency, Internal Medicine, 2015 - 2016- Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2012 - 2015
The Pennsylvania State UniversityPhD, Molecular Toxicology, 2007 - 2012
N.H.L Municipal Medical CollegeClass of 2007, MBBS
Certifications & Licensure
NC State Medical License 2019 - 2025
NY State Medical License 2016 - 2020
TN State Medical License 2017 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected as Chief Resident Mount Sinai St. Luke's Roosevelt Hospital, 2015-2016
- US Patent # 8,802,680 2014
- Honors in Anatomy Smt. NHL Municipal Medical College, Ahmedabad, India, 2002
Publications & Presentations
PubMed
- 1 citationsActivation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells.Fenghua Qian, Shaneice K Nettleford, Jiayan Zhou, Brooke E Arner, Molly A Hall
Cell Reports. 2023-07-25 - 22 citationsOverall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH.Robert F. Cornell, Parameswaran Hari, Shijie Tang, Noa Biran, Natalie S. Callander
American Journal of Hematology. 2021-01-01 - 411 citationsOutcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy.Ujjawal H. Gandhi, Robert F. Cornell, Arjun Lakshman, Zhubin Gahvari, Elizabeth McGehee
Leukemia. 2019-09-01
Research History
- Graduate Research AssistantPenn State University, PhD - Molecular Toxicology2008 - 2012
Professional Memberships
- Member
- Member
- Member
- Member
Other Languages
- Hindi, Gujarati
External Links
- Practice profilehttps://findadoc.unchealthcare.org/details/47230/ujjawal-gandhi-cancer-hematology-cary
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
